DAURISMO
Pfizer Inc.
Application Filed: 2018-05-25
Trademark Application Details
SECOND EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87936058 |
| Registration Number | 6521117 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Richard A. Friedman |
| Attorney Docket Number | T423299 |
| Law Office Assigned | L80 |
| Employee Name | OESTREICHER, SALIMA PA |
Timeline
| 2018-05-25 | Application Filed |
| 2018-10-09 | Published for Opposition |
| 2018-12-04 | Location: INTENT TO USE SECTION |
| 2019-10-22 | Status: Live/Pending |
| 2019-10-24 | Transaction Date |
| 2021-10-12 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Pfizer Inc. |
| Address | 235 East 42nd Street New York DE 10017 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use |
| GS0051 | Pharmaceutical preparations for the treatment of cancer |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-05-29 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-06-02 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-08-29 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-08-31 | 4 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-09-19 | 5 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-10-09 | 6 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-10-09 | 7 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-12-04 | 8 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-05-01 | 9 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2019-05-01 | 10 EXT1 S: |
| EXTENSION 1 GRANTED | 2019-05-01 | 11 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-05-03 | 12 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-10-22 | 13 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2019-10-22 | 14 EXT2 S: |
| EXTENSION 2 GRANTED | 2019-10-22 | 15 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-10-24 | 16 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-05-19 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2020-05-19 | 18 EXT3 S: |
| EXTENSION 3 GRANTED | 2020-05-19 | 19 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-05-21 | 20 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2020-09-25 | 21 EISU I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2020-09-25 | 22 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-10-02 | 23 AITU A:Allowance for Publication |
| EXTENSION 4 FILED | 2020-09-25 | 24 EXT4 S: |
| EXTENSION 4 GRANTED | 2020-10-02 | 25 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-10-03 | 26 EXRA E:E-Mail |
| USE AMENDMENT FILED | 2020-09-25 | 27 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2021-08-03 | 28 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2021-09-09 | 29 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2021-09-10 | 30 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2021-10-12 | 31 R.PR A:Allowance for Publication |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-03-28 | 32 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-03-28 | 33 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-03-28 | 34 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-03-28 | 35 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-03-28 | 36 CHAN I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 DAURISMO 88980015 not registered Live/Pending |
Pfizer Inc. 2018-12-04 |
 DAURISMO 88215704 not registered Live/Pending |
Pfizer Inc. 2018-12-04 |
 DAURISMO 87936058 not registered Live/Pending |
Pfizer Inc. 2018-05-25 |
 DAURISMO 86454277 not registered Dead/Abandoned |
Pfizer Inc. 2014-11-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 